Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
Advancing Rapid Microbial Detection with Celsis®
11 Mar 2026
MICROBIOLOGY EVENTS
-
2026 QC Micro Summit
17 Mar 2026 -
Advanced Therapies
17 Mar 2026 -
ISPE Aseptic Conference 2026
23 Mar 2026 -
Analytica 2026
24 Mar 2026 -
GMP PharmaCongress and GMP PharmaTechnica Expo 2026
24 Mar 2026 -
What Does Whole Genome Sequencing Reveal About Anaerobic Bacteria?
26 Mar 2026 -
Bacillus cereus Cereulide Toxin in Powdered Infant Formula
26 Mar 2026 -
ESCMID Global 2026
17 Apr 2026 -
Essentials Of USP Microbiology - Reading Between the Lines of the USP General
28 Apr 2026 -
A Practical Introduction to Sterile Manufacturing
28 Apr 2026